Inhaled corticosteroid prescribing from the emergency department for children with asthma

Glenn Clinton Shedd1, Dian Dowling Evans

  • 1Department of Family and Community Nursing, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia 30322, USA. gshedd@emory.edu

Insights

This study analyzed emergency department data to understand inhaled corticosteroid prescribing for pediatric asthma. Findings highlight potential gaps in guideline adherence for asthma exacerbation management in children.

Area of Science:

  • Pediatric Emergency Medicine
  • Pulmonology
  • Health Services Research

Background:

  • Asthma is a common chronic respiratory disease in children.
  • Inhaled corticosteroids (ICS) are foundational for persistent asthma control.
  • Guidelines recommend ICS for moderate-to-severe persistent asthma and during exacerbations.

Purpose of the Study:

  • To analyze the frequency of inhaled corticosteroid (ICS) prescription for children with asthma in US emergency departments.
  • To evaluate ICS prescribing patterns in relation to current asthma management guidelines.
  • To assess the implications of prescribing patterns for emergency department (ED) practice.

Main Methods:

  • Secondary data analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) database.
  • Examined demographic and clinical characteristics of pediatric asthma visits.
  • Assessed ICS prescribing rates among children diagnosed with asthma in the ED.

Main Results:

  • The study identified specific trends in ICS utilization for pediatric asthma patients in emergency settings.
  • Prescribing patterns were analyzed in the context of asthma severity and exacerbation management.
  • Variations in ICS prescription frequency were observed, suggesting potential areas for practice improvement.

Conclusions:

  • The findings underscore the importance of adhering to national guidelines for ICS use in pediatric asthma exacerbations.
  • Opportunities exist to optimize ICS prescribing in emergency departments to improve long-term asthma control.
  • This research provides valuable insights for clinicians managing pediatric asthma in acute care settings.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...